No Harm in Reducing Use of Roche Drug for Breast Cancer, Study Says

Treating breast-cancer patients with an expensive Roche drug for six months instead of 12 reduced heart-related side effects without sacrificing effectiveness, a new study found.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News